Thinking of joining a study?

Register your interest

Become a volunteer?

NCT07019766 | RECRUITING | T-LGL Leukemia

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
Sponsor:

Institute of Hematology & Blood Diseases Hospital, China

Brief Summary:

Hematological diseases are disorders of the blood and hematopoietic organs. The current hematological cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in hematology. The objectives of this study are to investigate the incidence and risk factors of large granular lymphocytic leukemia (LGLL) and to analyze the treatment effectiveness, patient prognosis, and healthcare costs in China. 1. Analyze the demographic and clinical characteristics of patients with LGLL, including sex, age, disease severity, and other relevant factors. 2. Examine disease features of LGLL patients, such as biochemical and hematological indicators, LGL counts, clonality, bone marrow pathology, and cytogenetics 3. Assess treatment patterns and real-world effectiveness in LGLL patients. 4. Evaluate clinical outcomes, including hematologic response, relapse, and mortality 5. Investigate long-term prognosis, including post-discontinuation outcomes and health-related quality of life.

Condition or disease

T-LGL Leukemia

NK-LGL Leukemia

Intervention/treatment

A combined retrospective and prospective observational follow-up

Study Type : OBSERVATIONAL
Estimated Enrollment : 9999 participants
Official Title : National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
Actual Study Start Date : 2000-01-01
Estimated Primary Completion Date : 2070-12-31
Estimated Study Completion Date : 2070-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Subjects diagnosed with LGLL.
  • * Subjects treated at the Institute of Hematology and Blood Diseases Hospital from Jan 1, 2000.
Exclusion Criteria
  • * Subject unlikely to be available for long-term follow-up for any reason (e.g., inability to obtain follow-up data or presence of severe comorbidities).
  • * Subject with alcohol or drug dependence that may reduce their compliance with the study.
  • * Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study.
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Location Details

NCT07019766

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

China, Tianjin Municipality

Red Blood Cell Diseases Center and Regenerative Medicine Center

Tianjin, Tianjin Municipality, China, 301617